CGMs containing a sensor electrode that is partially or completely coated with one or more layers of a material containing zwitterionic polymers are disclosed. With just a single calibration after implantation, CGMs containing the zwitterionic polymer coatings show reduced discordance between detected and actual blood glucose levels, during the crucial first one to three days, where current commercially available CGMs tend to show discordance with actual blood glucose levels.
